{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:39Z","timestamp":1767702879482,"version":"3.48.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"DOI":"10.7759\/cureus.100910","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:10:11Z","timestamp":1767701411000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Repeated Thrombolysis for Obstructed Mechanical Mitral Valve Prosthesis: A Case Report From a Resource-Limited Setting"],"prefix":"10.7759","author":[{"given":"Milan","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nileshkumar","family":"Khanpara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayvirsinh","family":"Atodariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner H","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, et al.. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017, 38:2739-91. 10.1093\/eurheartj\/ehx391","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.071183","article-title":"Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut R","year":"2007","unstructured":"Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007, 93:137-42. 10.1136\/hrt.2005.071183","journal-title":"Heart"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021, 143:e72-e227. 10.1161\/CIR.0000000000000923","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian A","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al.. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022, 43:561-632. 10.1093\/eurheartj\/ehab395","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2012.10.016","article-title":"Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial","volume":"6","author":"\u00d6zkan M","year":"2013","unstructured":"\u00d6zkan M, G\u00fcnd\u00fcz S, Biteker M, et al.. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging. 2013, 6:206-16. 10.1016\/j.jcmg.2012.10.016","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins DA","year":"2017","unstructured":"Watkins DA, Johnson CO, Colquhoun SM, et al.. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017, 377:713-22. 10.1056\/NEJMoa1603693","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu449","article-title":"Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)","volume":"36","author":"Z\u00fchlke L","year":"2015","unstructured":"Z\u00fchlke L, Engel ME, Karthikeyan G, et al.. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015, 36:1115-22a. 10.1093\/eurheartj\/ehu449","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.1.30","article-title":"The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis","volume":"87","author":"Silber H","year":"1993","unstructured":"Silber H, Khan SS, Matloff JM, Chaux A, DeRobertis M, Gray R. The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation. 1993, 87:30-7. 10.1161\/01.cir.87.1.30","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs486","article-title":"Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies","volume":"34","author":"Karthikeyan G","year":"2013","unstructured":"Karthikeyan G, Senguttuvan NB, Joseph J, Devasenapathy N, Bahl VK, Airan B. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J. 2013, 34:1557-66. 10.1093\/eurheartj\/ehs486","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom JW","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, et al.. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013, 369:1206-14. 10.1056\/NEJMoa1300615","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.876706","article-title":"Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial","volume":"120","author":"Karthikeyan G","year":"2009","unstructured":"Karthikeyan G, Math RS, Mathew N, et al.. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation. 2009, 120:1108-14. 10.1161\/CIRCULATIONAHA.109.876706","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.04.025","article-title":"Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial","volume":"170","author":"\u00d6zkan M","year":"2015","unstructured":"\u00d6zkan M, G\u00fcnd\u00fcz S, G\u00fcrsoy OM, et al.. Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial. Am Heart J. 2015, 170:409-18. 10.1016\/j.ahj.2015.04.025","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2392w","article-title":"Treatment of prosthetic valve thrombosis: current evidence and future directions","volume":"7","author":"Biteker M","year":"2015","unstructured":"Biteker M, Altun I, Basaran O, Dogan V, Yildirim B, Ergun G. Treatment of prosthetic valve thrombosis: current evidence and future directions. J Clin Med Res. 2015, 7:932-6. 10.14740\/jocmr2392w","journal-title":"J Clin Med Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18203\/2349-2902.isj20231728","article-title":"Thrombolytic therapy as first-line treatment in prosthetic mitral valve thrombosis","volume":"10","author":"Potwar S","year":"2023","unstructured":"Potwar S, Kothari A, Potnis A, Paranjape M. Thrombolytic therapy as first-line treatment in prosthetic mitral valve thrombosis. Int Surg J. 2023, 10:1019-23. 10.18203\/2349-2902.isj20231728","journal-title":"Int Surg J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2025.4369","article-title":"Tenecteplase vs alteplase in mechanical prosthetic heart valve thrombosis: the TENET randomized clinical trial","author":"Sharma G","year":"2025","unstructured":"Sharma G, Akkineni KP, Makkar N, et al.. Tenecteplase vs alteplase in mechanical prosthetic heart valve thrombosis: the TENET randomized clinical trial. JAMA Cardiol. 2025, 10.1001\/jamacardio.2025.4369","journal-title":"JAMA Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2009.01.007","article-title":"Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases","volume":"102","author":"Roudaut R","year":"2009","unstructured":"Roudaut R, Lafitte S, Roudaut MF, et al.. Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis. 2009, 102:269-77. 10.1016\/j.acvd.2009.01.007","journal-title":"Arch Cardiovasc Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/jicc.jicc_44_24","article-title":"Efficiency of thrombolytic therapy in mechanical prosthetic valve thrombosis: a comprehensive study from a tertiary care center","volume":"15","author":"Tammiraju","year":"2025","unstructured":"Tammiraju, Iragavarapu,Teja, et al.. Efficiency of thrombolytic therapy in mechanical prosthetic valve thrombosis: a comprehensive study from a tertiary care center. J Indian Coll Cardiol. 2025, 15:61-5. 10.4103\/jicc.jicc_44_24","journal-title":"J Indian Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.111109","article-title":"Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results","volume":"140","author":"Gupta D","year":"2000","unstructured":"Gupta D, Kothari SS, Bahl VK, Goswami KC, Talwar KK, Manchanda SC, Venugopal P. Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results. Am Heart J. 2000, 140:906-16. 10.1067\/mhj.2000.111109","journal-title":"Am Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450454-successful-repeated-thrombolysis-for-obstructed-mechanical-mitral-valve-prosthesis-a-case-report-from-a-resource-limited-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:10:11Z","timestamp":1767701411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450454-successful-repeated-thrombolysis-for-obstructed-mechanical-mitral-valve-prosthesis-a-case-report-from-a-resource-limited-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.100910","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}